Pristane promotes anaerobic glycolysis to facilitate proinflammatory activation of macrophages and development of arthritis
Highlights: • Pristane-induced arthritis is dependent on macrophages with M1 phenotype. • Pristane causes mitochondrial dysfunction and metabolic abnormalities in macrophages. • Macrophages treated by pristane show increased glycolysis flux and enzyme activity. • Metabolic reprogramming of macrophages controls M1 polarization and arthritis. Pristane-induced arthritis (PIA) could be adoptively transferred by splenic T cells in rats, and innate immunity should play critical roles in T cell activation. However, in pre-clinical stage, the activation mechanism of innate cells like macrophages remains unclear. Here we found that PIA was dependent on macrophages since cell depletion alleviated disease severity. Splenic macrophages of PIA rats showed M1 phenotypic shifting. The quantitative proteomics analysis suggested that macrophages initiated metabolic reprogramming with the conversion of aerobic oxidation to glycolysis in response to pristane in vivo. Notably, macrophages treated with pristane showed mitochondrial dysregulation and increased glycolysis flux and enzyme activity. Additionally, TNFα production, strongly associating with the glycolysis enzyme Ldha/Ldhb, could be reduced as glycolysis was inhibited or be enhanced as citrate cycle was blocked. This work provides detailed insights into the molecular mechanisms of pristane-mediated metabolic reprogramming in macrophages and suggests a new therapeutic strategy for arthritic disorders.